-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare
Overview ( as on 06/01/26 )
NAV
₹40.28
Last change
₹0.16 +0.0%
Fund Size (AUM)
6459.82 Cr
Performance
17.56% (5Y)
Fund Details
ICICI Pru Pharma Healthcare Diag Growth
as of 06/01/26
AUM
6459.82 Cr
Expense Ratio
1.86 %
Benchmark
BSE Healthcare TR INR
ISIN
INF109KC1GE9
Fund Manager
Dharmesh Kakkad
Exit Load
1.0% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| ICICI Pru Pharma Healthcare Diag Growth | 1.33% | 28.08% | 17.56% |
| BSE Healthcare TR INR | -3.26% | 23.89% | 15.1% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
12.83% |
Dr Reddy's Laboratories Ltd |
9.81% |
Cipla Ltd |
8.0% |
Divi's Laboratories Ltd |
7.48% |
Aurobindo Pharma Ltd |
6.04% |
Lupin Ltd |
5.7% |
Mankind Pharma Ltd |
5.04% |
Alkem Laboratories Ltd |
3.78% |
Syngene International Ltd |
2.97% |
Cohance Lifesciences Ltd |
2.68% |
Sector Allocation
Healthcare |
97.66% |
Basic Materials |
1.19% |
Financial |
1.15% |
Asset Allocation
-
98%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
17.56% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
16.9% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
14.65% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
14.65% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
14.65% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R
Equity healthcare-
Returns
-
15.83% (5Y)
-
